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1. Introduction  
Tinnitus is defined as a non-specific symptom characterized as buzzing, whistling, 
fizzing, ringing or sensing of wide frequency range and different intensity sounds in one 
or both ears. Tinnitus is a sensation of sound perceived by an individual in the absence of 
an external sound source. It affects approximately 15% of the population worldwide.  
Tinnitus is usually connected with many kinds of hearing disturbances, but it could be 
also a symptom of different other health problems. Metabolic syndrome and its 
components as arterial hypertension, diabetes mellitus, obesity and dyslipoproteinaemia 
with arteriosclerosis are important and frequent causes of tinnitus. Due to the high 
number of heterogeneous etiologic factors in subjective and objective tinnitus a complex 
approach in differential diagnosis is crucial. Tinnitus can be a concomitant symptom to 
many disorders of peripheral statoacoustic apparatus. It is necessary to distinguish 
whether tinnitus is an acute symptom in onset, e.g. in Menière’s disease, acute trauma, 
inflammation of the inner ear, or it is a part of chronic disease otological in origin. Various 
cardiovascular diseases can be the cause of newly arisen or persistent tinnitus. Among the 
most important causes there is a reduced perfusion with ischemic changes. Vascular 
changes can be localized either extra- or intracranially. Among them are stenosis of 
arteries, haemangioma and glomus caroticum tumours. Changes in the rheology of blood 
in anaemia or polycythemia can be the cause of tinnitus, as well. It is important to think 
also about vasculitis as a cause of tinnitus especially among younger patients. Diagnosis 
of hypertension requires serious and careful approach. The use of a 24-hour ABPM should 
be considered and carried out as soon as possible in patients with presence of tinnitus. 
Despite our results are from the limited number of patients with tinnitus, the diagnostic of 
arterial hypertension is very important, as several prospective studies have reported that 
ABPM give better prediction of clinical outcomes compared with conventional clinic or 
office blood pressure measurements. The inner ear, like the brain, is totally lacking in 
energy reserves. Its metabolism depends directly on the supply of oxygen and glucose 
from the blood supply. Alterations in glucose metabolism therefore have great potential 
for disturbing the workings of the inner ear. 
www.intechopen.com
 Up to Date on Tinnitus 
 
118 
2. Classification of tinnitus 
a. Objective tinnitus 
Objective tinnitus is usually of rhythmical character and can be registered. It can arise from 
muscle spasms or alteration to the vessels. Although there is a wide spectrum of these 
disorders, objective tinnitus is not very common, only about 1-2 % of all tinnitus cases 
(Møller, 2007). 
b. Subjective tinnitus 
Subjective tinnitus is defined as the perception of sound on the absence of an internal or 
external sound source. Subjective tinnitus is perceived only by a patient. Its origin is in acoustic 
analyser or in the brain. Tinnitus itself is not a disease. It is a symptom going along with other 
diseases. But in fact it can be a dominant sign of the whole clinical picture especially when it is 
persistent, it has increasing intensity and negative effect on work ability and psychosomatic 
status. The etiology of a majority of cases is not known (Feldmann, et al., 1992).  
It has to be distinguished from acoustic hallucinations as a part of some psychiatric 
disorders. The most frequent causes of tinnitus are shown in table 1. 
 
Disorders of acoustic analyzer and central nervous system 
Alternation of the structures of the inner ear and acoustic nerve 
Menière’s disease 
Infection of the inner ear and sinuses 
Acoustic trauma 
Chronic noise exposure 
Otosclerosis 
Neurinoma of the auditory nerve 
Arterial hypertension 
Arterial hypotension 
Diabetes mellitus 
Arteriosclerosis 
Aneurysm 
Disorders of metabolism 
Kidney diseases 
Head and neck trauma 
Cervical spine and temporomandibular joint diseases 
Hematological diseases with the change in viscosity of blood and changes in 
microcirculation 
Exogenous noxious substances – nicotine, alcohol, caffeine 
Medications: antibiotics, NSAIDs, antidepressants, cytostatics, furosemide, oral 
contraceptives 
Industrial toxins – heavy metals, carbon monoxide, aniline, benzol 
Artificial sweeteners containing aspartame 
Lues 
Autoimmune diseases 
Table 1. The most frequent causes of tinnitus 
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Tinnitus is described as an unwelcome symptom. Tinnitus can be an attendant phenomenon 
in specific diseases, but in some cases his origin and cause is unknown. Through the precise 
etiology in most cases is unknown, an abnormal interaction between peripheral and central 
auditory pathways is believed to play a role in tinnitus development. Tinnitus is associated 
with the most important symptoms in neurootology, besides vertigo, nausea and hearing 
loss. There are many forms of subjective tinnitus witch can occur with different severity. 
The parameters of tinnitus that require identification are intensity, location, duration, 
quality, maskability and rebound. The patient may report the intensity as mild, moderate or 
severe. Various grading systems have been used to provide a means of communication 
between the patient and examiner.  
The biological mechanisms leading to the perception of tinnitus are still not completely 
understood. Increasing agreement, however, posits that different forms of tinnitus may 
differ in their patophysiological mechanisms. Also generally accepted is that most forms of 
subjective chronic tinnitus are the consequence of central nervous system reorganization 
processes induced by altered peripheral auditory and somatosensory input. Peripheral 
deafferentation may result in an imbalance between excitatory and inhibitory function, 
causing maladaptive plastic changes in the structural and functional organization of the 
auditory system at several levels (dorsal cochlear nucleus, inferior colliculus, medial 
geniculate body and auditory cortex). 
Sudden sensorineural hearing loss is defined as hearing loss equal to or greater than 30 dB 
at three or more consecutive frequencies, the onset of which takes place over a period 3 
days of fewer. In most cases, it is severe, nonfluctuating, unilateral and idiopathic. 
Approximately one-third of cases are accompanied by complains of tinnitus, dizziness 
and ear fullness. 
3. Obesity and metabolic syndrome 
Obesity is a chronic progressive disease characterized by the accumulation of fat tissue with 
multiple organ-specific pathological consequences which has a significant impact on 
morbidity, as well as the quality and length of the obese individuals` life. 
The prevalence of obesity in many European Union countries has tripled since the year 1980 
and further is increasing alarmingly, only during the last 10 years the number of obese has 
increased by 10 to 40%. Obesity is responsible for 2-8% of the costs and 10 to 13% of deaths 
in the region of the European Union. Overweight and obesity in the European region has 
more than 50% of the population. 20% of children and adolescents are overweight and a 
third of them are obese (Branca et al., 2007). Data from United States show that 65% of the 
local population has excess weight and 31% are obese. These data highlight the epidemic 
situation of obesity, and therefore the WHO considers reversing of this trend as one of its 
priorities (Haslam & James, 2005). 
In Table 2 are examples of the connection of obesity with a number of associated diseases 
and conditions. 
An abdominal adiposity as the cardiovascular risk factor is associated with components of 
metabolic syndrome, namely with insulin resistance, disturbed glucose metabolism, 
hypertension and dyslipidemia. With these components it is very closely linked to 
acceleration of the process of atherosclerosis and its serious systemic complications. It is 
important that the effect of these components (factors) together in mutual combination is not 
simply added, but multiplied. 
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Cardiovascular disease: coronary artery disease, myocardial infarction, systemic arterial 
hypertension, atherogenic dyslipidemia, stroke 
Oncologic diseases: endometrial and ovarian cancer, prostate, breast, rectum, kidney, liver, 
gallbladder cancer 
Diabetes mellitus type 2 and insulin resistance 
Hepatic steatosis 
Osteoarthropathy 
Deep vein thrombosis and pulmonary embolism 
Chronic renal failure 
Polycystic ovary syndrome 
Hyperuricemia 
Gallstones 
Reproductive disorders 
Lumboischialgic syndrome 
Ventilation pulmonary complications 
Sleep apnea syndrome 
Psychological and social problems 
Complications in pregnancy 
Complications in the perioperative period 
Table 2. Obesity is connected with a number of associated diseases and conditions 
Obesity and overweight are important markers of coronary heart disease and lead to an 
increase in cardiovascular and cerebrovascular morbidity and mortality (Narkiewicz, 2006). 
Adipose tissue is an endocrine organ. It synthesizes and releases several specific 
components, eg. cortisol, estrogen, leptin, adiponectin, resistin, nonesterified free fatty acids, 
interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha), plasminogen activator 
inhibitor-1 (PAI-1) and others. These influence and are in relationship to the overall 
cardiometabolic risk in an individual patient (Bonora, 2006). Many epidemiological studies 
show that prevalence of hypertension increases progressively with increasing BMI (body 
mass index) as for men as well as in women. Relationship between BMI and blood pressure 
(BP) is stronger for systolic (SBP) as the for diastolic (DBP) blood pressure. Data from the 
NHANES III study (Foley et al., 2005) clearly indicate, that the risk of hypertension 
developing is closely relate to the waist, as well as waist / hip ratio (WHR). In general, it is 
estimated that in about 75% of men with hypertension and in 65% of women with 
hypertension is present overweight or obesity. Data from the Finnish population studies 
suggest up to 85% prevalence of hypertension in persons with BMI over 25 kgm2 
(Kastarinen et al., 2000). Obesity and particularly central obesity leads to increased 
cardiovascular risk. Results of population studies suggest that at least two thirds of the 
prevalence of hypertension can be directly attributed to the impact of the obesity (Krauss et 
al., 1998). 
3.1 Pathophysiological changes in the cardiovascular system in obesity 
In the obesity there is a change in the fundamental characteristics of circulation, as heart 
stroke volume and cardiac output, peripheral vascular resistance, changes in the flow 
distribution. It leads, in association with other risk factors, to the development of arterial 
hypertension and coronary heart disease. The degree of obesity correlates directly with 
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cardiac output and is inversely associated with systemic vascular resistance. The increase in 
cardiac output in obese is resulting from an increased stroke volume, while heart rate does 
not correlate with BMI (Kurtz & Klein, 2009; Messerli et al., 1981). Stroke volume is probably 
associated with an increased intravascular volume (non-obese 50 ml/kg vs. obese 75 
ml/kg). Central type of obesity, however, is associates with lower cardiac output and higher 
total peripheral vascular resistance, and the deviation of above parameters is even increased 
by the mental stress.  Splanchnic blood flow is increased by 20%, flow through the kidneys 
and the brain remains unchanged (Jern et al., 1992). Distribution of body fat influences the 
muscle morphology and density of the muscle capillary network. Persons with a higher 
waist circumference have less type I muscle fibers and more type IIB fibers. Type IIB has 
about 20 to 30% lower density of capillary network. In the case of stress response can be 
expected to lower vasodilative response in the muscles, followed by the less efficient 
splanchnic vasoconstriction in stress defense response. Abdominal obesity has been 
associated with increased activity of hypothalamic-pituitary-adrenal axis, which is a major 
part of the neuroendocrine system that controls reactions to stress and defense reaction 
(Howell et al., 2004; Rahmouni et al., 2005). 
There is a higher cardiac output in obese individuals, higher circulating intravascular 
volume and increased oxygen consumption, but total blood flow in relation to body weight 
is reduced. An increased sympathetic activity is also common in obesity, which may in long-
term activation cause hypertension by the peripheral vasoconstriction and increased tubular 
reabsorption. Studying regional sympathetic activity in obese subjects was found an excess 
of noradrenaline in relation to the kidneys as a key organ of cardiovascular homeostasis. 
Both obesity and hypertension lead to the development of left ventricular hypertrophy and 
subsequent diastolic dysfunction (Redon et al., 2008). 
Adipose tissue is through several mechanisms, directly integrated into the pathogenesis of 
hypertension. These mechanisms include alteration of renin-angiotensin-aldosterone system 
(RAAS), increased activity of the sympathetic nervous system, insulin resistance, leptin 
resistance, alteration of coagulation and inflammatory factors in the development of 
endothelial dysfunction. Activation of adipose RAAS is involved particularly in the creation 
and development of hypertension in the central (visceral) type of obesity. Especially in this 
type of obesity is increased level of plasma aldosterone (Goodfriend & Calhoun, 2004). The 
cause of the increase in production can be potent mineralocorticoid-releasing factors, or 
effect of oxidised linolenic acid compounds on aldosterone synthesis (Goodfriend et al., 
2004). 
Leptin is a link between adiposity and increased sympathetic activity. In addition to effects 
on appetite and metabolism, leptin increases blood pressure by the sympathetic activation in 
hypothalamus (Carlyle et al., 2002). Understanding the role of leptin in the pathophysiology 
of sympathetic overactivity in obese patients facilitates the concept of selective leptin 
resistance. Leptin-induced increase in renal sympathetic activity and blood pressure is 
mediated by the ventromedial and dorsolateral hypothalamus (Marsh et al., 2003). 
Selectivity refers to the different signaling pathways distal to the leptin receptor. Enzyme 
fosfoinozitol-3 kinase is an important intracellular signaling pathway for the control of renal 
sympathetic systeme, because inhibition of this enzyme reduces sympathetic activity. 
Melanocortin system is also an important regulatory axis, with the effects on renal 
sympathetic and blood pressure (da Silva et al., 2004). 
Hypertension contributes to increased cardiovascular and cerebrovascular morbidity and 
mortality through effects on atherogenesis by multiple mechanisms: it leads to endothelial 
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dysfunction with impairment of responses to vasodilatating substances, to increased 
vascular permeability for macromolecules (also for lipoproteins), to the increased 
production of vasoconstrictor endothelin and to increased adherence of leukocytes, also 
to the remodeling of smooth muscles in large arteries, whereas in small arteries it 
causes increased vascular tone. An increase in angiotensin II level and PDGF act as 
growth factors for smooth muscle cells of the media, their effect is potentiated by the 
endothelin. Phenotypic change of vascular smooth muscle cells may also occur, thus 
increasing their proliferative potential and their proliferative response to growth factors 
(Fábryová, 2008). 
Endothelial dysfunction in terms of reduced reactivity to nitric oxide (NO) is a typical 
abnormality in obesity. Impaired endothelium is a major risk factor for cardiovascular 
diseases because it leads to structural changes such as the rebuilding of the intima and 
media of wall of blood vessels. Strong factor for the development of endothelial dysfunction 
is the increased production of endothelin-1 in patients with hypertension and obesity. 
Blockade of endothelin receptor-A induces significant vasodilation in subjects with 
overweight and obesity, but not in the case of normal-weight patients with hypertension 
(Cardillo et al., 2004).  
Obesity is associated with several structural and functional changes in kidneys. RAAS and 
sympathetic activation increases the levels of plasma aldosterone with consequent increases 
in renal sodium reabsorption, which leads to impaired sodium excretion and the expansion 
of circulating blood volume. Obesity can also cause structural changes in the kidney, leading 
to chronic renal failure with a further increase in blood pressure. Mechanic pressure of 
abdominal adipose tissue in the visceral type of obesity may have also a role in renal 
impairment. Besides sympathetic autonomic nervous system also the leptin plays a role, 
which acts directly by increasing oxidative stress with a demonstrable increase in 
isoprostane levels in blood and urine, increased lipid peroxidation products in kidney tissue 
and decreased renal activity of aconitase (Beltowski et al., 2004). Obesity can cause 
glomerular hyperfiltration, abnormal albuminuria and progressive loss of kidney function 
due to focal segmental glomerulosclerosis (Kambham et al., 2001). Number of nephrons is 
reduced in patients with primary hypertension (Keller et al., 2003). In patients with pre-
existing renal disease, obesity accelerates the progression of the disease and renal 
insufficiency (Praga et al., 2000). Structural kidney damage may further increase blood 
pressure and predispose to cardiovascular events. 
3.2 Pathophysiological changes in the respiratory system in obesity 
Obesity, especially abdominal type, is associated with deterioration of pulmonary function. 
Abdominal obesity is limiting diaphragm descent and expansion of lung parenchyma, in 
comparison with total adiposity, which compresses the chest wall. Compression of the lung 
parenchyma leads to decrease in expiratory reserve volume and functional residual 
capacity, which reduces the compliance of respiratory system. In obese patients with 
normocapnia breath work is at rest increased by 30%, in physical activity may be insufficient 
breath work limit for further increase in minute output with development of the relative 
hypoventilation. Products associated with abdominal type of obesity, such as serum leptin, 
CRP, leukocytes, fibrinogen have an inverse relationship to FEVl, therefore, inflammation 
may be connection between altered respiratory function and mortality (Schünemann et al., 
2000; Sin & Man, 2003). 
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3.3 Obesity and sleep apnea syndrome  
Obesity is associated with sleep apnea syndrome and obesity hypoventilation syndrome 
(Pickwickian syndrome, alveolar hypoventilation). In sleep apnea syndrome, pharyngeal 
airway passive collapse during deep stages of sleep, causing snoring and intermittent 
airway obstruction. The resulting hypoxia and hypercapnia cause disturbance of the normal 
sleep quality and subsequent daytime sleepiness, development of pulmonary and systemic 
vasoconstriction, polycythemia and right heart failure. Relative hypoventilation may cause 
progressive desensitization of respiratory centers to hypercapnia, followed by respiratory 
insufficiency. 
Obesity hypoventilation syndrome is one of several diseases associated with chronic 
hypercapnia and alveolar hypoventilation. Obesity is associated with increased risk of 
alveolar hypoventilation and carbon dioxide retention. Hypoxemia and increased alveolar-
arterial oxygen gradient in patients with obesity hypoventilation syndrome draws attention 
not only to alveolar hypoventilation, but also the ventilation - perfusion mismatch. 
Patients with chronic obstructive pulmonary disease and sleep apnea, as well as patients 
with obesity hypoventilation syndrome in addition to systemic arterial hypertension also 
have high prevalence of pulmonary arterial hypertension (Nowbar et al., 2004; Šimková, 
2009). 
It is clear that hypertension dependent on obesity is a multifactorial disease. Obese 
individuals tend to hypertension, but vice-versa, hypertensive individuals tend to weight 
gain. As the Framingham and Tecumseh studies also showed, that future weight gain is 
significantly greater in hypertensive than in normotensive persons. This finding indicates 
that the hypertensive patients, even with normal weight are at increased risk of developing 
obesity and other complications resulting from it (Julius et al., 2000). 
The link between increased BMI and mortality is documented by the analysis of 57 
prospective studies (Flegal et al., 2007). For both sexes, the lowest mortality was found in 
BMI from 22.5 to 25 kg/m2. In all age categories 35 to 59 years, 60 to 69 year, 70 to 79 y. and 
80 to 89 years was revealed significant increase in mortality in persons with BMI 25 to 50 
kg/m2. BMI in its entirety from 15 to 50 kg/m2 was associated almost linearly with systolic 
and diastolic blood pressure. Obesity was significantly associated with diabetes. This 
explains the positive and approximately log-linear relationship of BMI and an increase in 
the number of deaths due to ischemic heart disease with a 40% increase in CHD mortality 
for an increase in BMI for every 5 kg/m2. The same results were found for stroke. Mortality 
due to heart failure and hypertension was also strongly associated with higher BMI. 
Different groups of antihypertensive agents differ significantly in their metabolic effects. It is 
important to consider significant differences in this effect between different types of 
pharmaceuticals within the group itself, which is particularly true for beta-blockers. From 
the centrally acting antihypertensive drugs, it has been proven beneficial effect for weight 
reduction in moxonidine. Administration of ACE inhibitors and AT1 blockers is 
significantly reducing the risk of type 2 diabetes. Their complex beneficial effects affect not 
only the hypertension itself, but also the whole cascade of metabolic changes; therefore 
preparations that affect the renin-angiotensin system are essential treatment of hypertension 
in obesity and metabolic syndrome. From the group of sartans, telmisartan is unique 
substance in this respect, which significantly improves insulin sensitivity. From the drugs 
which may adversely affect weight and cause its sharp increase are particularly significant 
psychiatric medications. This undesirable side effect can be observed mainly in the 
traditional neuroleptics and tricyclic antidepressants (Svačina, 2002). 
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4. Metabolical disease 
Extensive laboratory tests should be performed at the time of the general medical evaluation 
in addition to sugar and thyroid metabolism to evaluate the status of serum cholesterol and 
triglycerides level. Triglyceride levels have been reported to be considered in evaluating 
patients with inner ear or Menière’s disease. There has been evidence of a positive 
experience in a small but significant number of patients, more male than female, for the 
identification of these factors in association with secondary endolymphatic hydrops. 
Significantly, the incidence of subjective idiopathic tinnitus in patients with diabetes 
mellitus has been infrequent in the series. The subjective idiopathic tinnitus was cochlear 
and was influenced positively by glucose control.  
Nutritional deficiencies and imbalances are considered of significance in relation to ear 
disease and specifically for complaints of sensorineural hearing loss, vertigo and tinnitus. 
The clinical history is correlated with laboratory test results, which attempt to identify 
imbalances, deficiencies, and/or excesses of nutrients that are considered to upset the 
biochemical balances of the hearing organ resulting in malfunction of hearing and/or 
balance process. Impaired carbohydrate metabolism and its control have been identified in a 
significant number of patients with Menière’s disease. The identification by clinical history 
and laboratory tests including determination of insulin levels, followed up by specific 
treatment to correct such an imbalance, is reported to significantly improve symptoms of 
endolymphatic hydrops (sensorineural hearing loss, vertigo, tinnitus). Hyperinsulinemia 
has three different effects: sodium retention within cochlear duct with a resulting 
endolymphatic hydrops, vasoconstriction caused by the effect of prolonged 
hyperinsulinemia in long term hypertrophy of arterial smooth muscles cells, and cholesterol 
formation and atherosclerosis within the arterial walls of the branches internal auditory 
artery. Impairment of glucose metabolism is of particular significance in the aged 
population. The chemical attachment of the sugar glucose to proteins without the aid of 
enzymes may contribute to age-related impairment of both cells and tissues. In this 
nonenzymatic process, glucose is described to have the capability of attaching itself to 
several sites along any available peptide chain. This process is called nonenzymatic 
glycosylation of certain proteins in the body. Glucose may play a role in tissue changes 
associated with normal aging. Elevated cholesterol and triglycerides levels have been 
reported with fluctuant hearing loss, vertigo, and tinnitus. A triad of elevated levels of 
insulin and triglycerides and impaired glucose tolerance has been reported, particularly in 
obese patients. The identification of these abnormalities combined with dietary control has 
been reported to result in considerable control of fluctuant sensorineural hearing loss, 
vertigo, and tinnitus. Association of a triad of hypertension and atherogenic diet and 
chronic noise exposure acts synergistically for the development of a sensorineural hearing 
loss (Pillsbury, 1986). 
5. Arterial hypertension and tinnitus 
Stabilization of the symptoms of hypertension has been found to have a significant positive 
influence on treatment in general and for the following clinical types of subjective idiopathic 
tinnitus (cochlear tinnitus, vestibular tinnitus and central tinnitus). Tinnitus has been found 
to be a "soft" sign of cerebro-vascular disease and secondary endolymphatic hydrops. For 
these clinical types of tinnitus as well as tinnitus of specific causes, blood pressure control 
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has afforded appreciable control. Ear and/or head blockage complaints should also be 
respected as an accompaniment of a possible "symptom less" hypertension. The term 
essential hypertension has been applied to idiopathic hypertension. Essential hypertension 
is marked by its heterogeneity and multifactorial nature. There have been identified clinical 
similarities between essential hypertension and subjective idiopathic tinnitus. Classically, 
patients have reported problems of tinnitus in association with elevated blood pressure. 
These are usually anecdotal reports, in the past, control of hypertension resulted in 
significant control of subjective idiopathic tinnitus. Therefore, the concept of and role of 
hypertension in the production and control of tinnitus is and old one. What is new is to 
reverse the thinking of hypertension as resulting in tinnitus to that of the presence of 
tinnitus as reflecting possible hypertension. In a significant number of tinnitus patient, the 
early identification of tinnitus has been accompanied by an elevation in blood pressure. 
Blood pressure control not only has resulted in a reduction in tinnitus intensity, but also has 
provided hearing conservation as well as the alteration or control of progression of 
complaints of cerebrovascular disease, cardiovascular complications, e.g. myocardial 
infarction, congestive heart failure, vertigo, progressive sensorineural hearing loss, and ear 
and/or head blockage. In a significant number of tinnitus patients, any or all of these 
symptoms together with that of tinnitus have been found to present as a symptoms complex 
reflecting an early manifestation of hypertension.  
The essential quality of the hypertension requires investigation and attention by the 
internist. This is a particularly evident among aged patients. In a significant number of 
patients in the aged group have either an acute onset of tinnitus and/or exacerbation of 
chronically present tinnitus accompanied by an elevation of blood pressure. The clinical 
correlation of hypertension and the tinnitus onset has also been found in the younger 
population, i.e., below age 40, but less frequently. Epidemiological studies concerning the 
relationship of blood pressure elevation with age concluded that this relationship has, as 
yet, not been determined (Morris, 2007). In some patients, blood pressure does increase with 
middle age. Some studies (Miall et al., 1967), did show positive correlation with advancing 
years. Tinnitus may be an early symptom that has wide-reaching consequences in a 
significant number of the aged population. The heterogeneity and multifactorial elements 
involved in essential hypertension, particularly in the aged, can explain the great degree of 
variability of its in tinnitus patients with or without hypertension. What is significant is that 
tinnitus may be a very early sign of onset of hypertension and/or an inadequate blood 
pressure control.  
Sodium and water retention and a reduction in urinary excretion are of particular 
significance for those subjective tinnitus patients who may have a vestibular asymmetry 
with or without subjective complaints of vertigo and who are diagnosed with secondary 
endolymphatic hydrops. Secondary endolymphatic hydrops may be considered in the 
subjective tinnitus patient to be a mechanism for gradual progressive sensorineural hearing 
loss. Its control has, in a significant number of patients, resulted in satisfactory tinnitus 
control. Significant is that the initial blood pressure increase, which has been shown to 
originate in an area other than that of the kidney, is, however, maintained by the kidney by 
complex changes occurring in renal dynamics, as manifested by fall in renal blood flow and 
renin and increase in total renal vascular resistance.  
Psychobiologic factors are significant for both subjective idiopathic tinnitus and essential 
hypertension. Essential hypertension can serve as can no other disease as model of the 
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multifactorial nature of all diseases in which complex interactions between inherited, 
environmental, social, cultural, experiential, physiological and biochemical factors occur. No 
single cause of essential hypertension appears to exist, no qualitative, discontinuous 
alteration has been discovered to explain its etiology or pathogenesis. Like essential 
hypertension, subjective tinnitus demonstrates heterogeneity of its manifestations, both for 
the mechanism involved in its production and/or its clinical manifestation. Both conditions 
share common factors including socio-economic, cultural, ethnic, behavioural and 
psychological factors.  
Consideration should be given to the group of tinnitus patients for whom adequate sleep is 
accompanied by reduction in tinnitus. It has been known for some time, that behavioural 
states can affect blood pressure levels, which are much lower in sleep, than in the waking state. 
In both states, psychological factors are significant. In essential hypertension, the psychological 
factors alone are not considered sufficient to explain the predisposition to or pathogenesis of 
the disorder. The physiologic heterogeneity that results in hypertension is reflected in the 
psychological heterogeneity. Future clinical investigations of the relationship between the 
sensory and affect components in both these health problems may clarify diagnosis, treatment 
and control of subjective idiopathic tinnitus. In both conditions, social and psychological 
factors interfere in the clinical results of the prescribed treatment. Hypertensive patients often 
do not follow treatment and medication regiments. Similarly, tinnitus patients may not accept 
a treatment method that may provide tinnitus relief, because the recommendations may not 
fulfils the patient’s expectation for cure or provide sufficient control. 
When developing treatment and control methods for both tinnitus and essential 
hypertension, the physician must consider that both are disorders not only of adaptation but 
also of regulation, which may be reflected in one or more systems. This has already been 
established for hypertension, and it may apply to tinnitus. 
6. Ambulatory Blood Pressure Monitoring (ABPM) in patients with tinnitus 
The aim of our study was to assess the prevalence of unknown arterial hypertension in 
patients with tinnitus. 
Patients and methods: We investigated 18 patients (8 female, 10 male) with median age 46 
(age spread 34 - 64 years) with tinnitus lasting from 4 months to 6 years. Known history of 
arterial hypertension and antihypertensive medication was an excluding criterion. After 
otorhinolaryngologic examination and estimating the tinnitus magnitude and frequency 
with pure tone audiometry with Interacoustics, Denmark AC40 audiometer (figure 1), we 
performed ambulatory blood pressure monitoring (ABPM) using CardioSoft - TONOPORT 
V - General Electric, USA device with oscilometric BP measuring (figure 2). 
The general medical-physical and otorhinolaryngologic examination should always precede 
the neurootologic investigation. The physical examination includes attention to the 
identification of any deformity or limitation of movement of the head, neck, spinal column, 
and joints. Inspection of the scalp and skull are supplemented by careful palpation to 
attempt to identify a localized thickening of the skull, abnormal scalp vessels, depressions of 
the skull, abnormal contours and asymmetry of the skull, past craniotomy, and/or other 
operative scars. In the presence of a large head, particularly in an adult, percussion is 
performed for evidence of possible hydrocephalus. Auscultation with a stethoscope is 
performed over the skull and neck for bruits. The effect on the bruit of head turning and 
compression of the carotid artery, right and left, back and forwards is noted. 
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Fig. 1. Clinical Audiometer AC 40, Interacustics, Denmark used for measurement of 
thresholds of audibility and specification of tinnitus. 
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Fig. 2. Cardiosoft – Tonoport – V – General Electric, USA device used for 24-hours ABPM 
Figure 3 shows audiogram with bilateral symmetric perceptive acoustic disorder. Then we 
performed internal examination and indicated a 24-hour ambulatory blood pressure 
monitoring (ABPM). We used for this examination Cardiosoft-Tonoport V-General Electric, 
USA device, which uses oscillometric method of measurement of blood pressure. None of 
the group member has previous known diagnosis of arterial hypertension, or use of any 
medication altering blood pressure level. As some medications can evoke or strengthen 
tinnitus thoroughly, history of patient’s medication is very important (Holcát, 2007). 
6.1 Results of our study 
The average values of blood pressure during a 24-hour ABPM were 140/89 mmHg. In 
daytime phase and nighttime phase the average values were 143/91 mmHg and 130/81 
mmHg, respectively. Diurnal sign was vanished in 5 individuals (28%). 6 persons (33%) had 
normotension during a 24-hour ABPM. 12 persons (66%) had hypertension with an average 
blood pressure values more than 130/80 mmHg for 24-hours. All records had a good quality 
what permits interpretation of ABPM profile including mean daytime, nighttimes, 24-hour 
measurement and diurnal pattern loss. Based on these results, we followed the patients from 
the group with abnormal ABPM results further and also with repeat measurement of casual 
blood pressure; we confirmed the arterial hypertension with necessity of antihypertensive 
drug treatment. 
7. Discussion 
Due to the high number of heterogeneous etiologic factors in subjective and objective tinnitus 
a complex approach in differential diagnosis is crucial. Tinnitus can be a concomitant 
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Fig. 3. Audiogram with bilateral symmetric perceptive acoustic disorder, decrease of hearing 
thresholds bilateral (red line – right ear, blue line – left ear) in frequency 3000-6000 Hz 
symptom to many disorders of peripheral statoacoustic apparatus. It is necessary to 
distinguish whether tinnitus is an acute symptom in onset, e.g. in Menière’s disease, acute 
trauma, inflammation of the inner ear, or it is a part of chronic disease otological in origin 
(Møller, 2003). Various cardiovascular diseases can be the cause of newly arisen or persistent 
tinnitus. Among the most important causes there is a reduced perfusion with ischemic 
changes. Vascular changes can be localized either extra- or intracranially. Among them are 
stenosis of arteries, haemangioma and glomus caroticum tumours. Changes in the rheology 
of blood in anaemia or polycythemia can be the cause of tinnitus, as well. It is important to 
think also about vasculitis as a cause of tinnitus especially among younger patients (König 
et al., 2006). 
The process of differential diagnosis usually starts at the otolaryngologist but 
interdisciplinary approach to the patient is needed. 
Tinnitus is frequent among patients with arterial hypertension, diabetes mellitus, thyroid 
gland disorders, rheumatologic and neurologic diseases. Two-thirds of our 18 patients with 
tinnitus had newly diagnosed hypertension during a 24-hour ABPM.  
The mean duration of tinnitus in our group was 4 years (range 4 months to 6 years). As none 
of the patients had formerly diagnosed hypertension, it is likely that hypertension arose 
after the onset and duration of tinnitus. Diagnosis of hypertension requires serious and 
careful approach and the use of a 24-hour ABPM should be considered and carried out as 
soon as possible in patients with presence of tinnitus. Despite that our results are from the 
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limited number of patients with tinnitus, the diagnostic of arterial hypertension is very 
important, as several prospective studies have reported that ABPM give better prediction of 
clinical outcomes compared with conventional clinic or office blood pressure measurements 
(Staessen et al., 1999). 
Tinnitus is a stressor, which can significantly decrease the quality of life, and it can cause 
serious mental disorders. Some circumstances (stress, acute infection, anaemia) can lead to 
increase of duration and intensity of tinnitus. Concomitant sleep disorders, anxiety, despair, 
frustration and depression as well as aggressiveness are related to higher frequency of 
psychosomatic disorders (Crönlein et al., 2007). Tinnitus then becomes a complex health 
problem and symptom becomes syndrome (Langguth et al., 2007). Due to the increased 
incidence of arterial hypertension in this group of patients a 24-hour ABPM is fully 
indicated. Approximately 17% of the population of USA and Europe and 15% of the 
population worldwide had manifestation of some form of tinnitus. Only half of them sought 
for medical help. In 15 - 20% of cases, tinnitus affects quality of life, with repercussions 
involving sleep habits, concentration, emotional stability and social activities (Axelsson & 
Ringdahl, 1989; Dobie, 1999). The degree of discomfort caused by this symptom may be 
mild when perceived by an individual only in particular situations (occurring among 
approximately 7% of the individuals); moderate when the individual is aware of its 
existence but does not feel bothered by it; intense when the unpleasant sensation is 
disturbing and has a negative effect on activities of daily living. It is severe when the 
symptom becomes unbearable, ever-present and ceaselessly affecting the activities of daily 
living with concomitant psychic problems. The degree of discomfort, intolerance, or 
incapacity caused to the individual is often not related to the loudness (sensation of 
intensity) of the tinnitus (Prestes & Gil, 2009). 
8. Conclusions 
1. Our result suggests that undetected hypertension is very often in patients with 
tinnitus. 
2. Arterial hypertension is one of many factors involved in tinnitus origin and 
continuing. 
3. ABPM is a suitable tool for hypertension detection and management also in this group 
of patients. 
4. Diagnosing and treating arterial hypertension may not influence tinnitus presence and 
intensity, but can avoid serious complications of hypertension e.g. stroke, myocardial 
infarction, heart or renal failure.  
5. Diabetes mellitus as one of the components of metabolic syndrome with its 
complications as micro- and macroangiopathy, cardiovascular autonomic neuropathy is 
an important and frequent etiologic factor of tinnitus. 
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